Showing results (261-270 of 436) with videos related to
Sort By:
Pageof 44
Seminars in Oncology|April 30, 2003
Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's MacroglobulinemiaRobert A Kyle, Steven P Treon, Raymond Alexanian, et al.Journal of Vascular and Interventional Radiology : JVIR|July 25, 2017
Combined Surgical and Transhepatic Rendezvous Procedure for Relieving Anastomotic Biliary Obstruction in Children with Liver TransplantsJohn Crowley, Kyle Soltys, Rakesh Sindhi, et al.Blood|July 16, 2005
Clinical factors predictive of outcome with bortezomib in patients with relapsed, refractory multiple myelomaPaul Gerard Guy Richardson, Bart Barlogie, James Berenson, et al.Blood|October 7, 2006
Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosisFenghuang Zhan, Bart Barlogie, Varant Arzoumanian, et al.Journal of Neurology|September 15, 2005
Population frequency of HLA haplotypes contributes to the prevalence difference of multiple sclerosis in IrelandChristopher McGuigan, Ciaran Dunne, John Crowley, et al.Rice (New York, N.Y.)|February 16, 2020
Construction and integration of genetic linkage maps from three multi-parent advanced generation inter-cross populations in ricePingping Qu, Jinhui Shi, Tianxiao Chen, et al.Frontiers in Plant Science|November 28, 2022
Genetic background- and environment-independent QTL and candidate gene identification of appearance quality in three MAGIC populations of riceHuizhen Chen, Laiyuan Zhai, Kai Chen, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 14, 2026
Targeting enhancing myelin regeneration reverses cognitive deficits in a mouse model of intellectual disabilityPingping Qiao, He Wang, Pingping Qu, et al.Blood|November 16, 2006
A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1John D Shaughnessy, Fenghuang Zhan, Bart E Burington, et al.Cancer|February 4, 2005
Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal functionSundar Jagannath, Bart Barlogie, James R Berenson, et al.Pageof 44